, Singapore
269 views
Photo from Pexels by RF Studio

Sanofi inaugurates $800m healthcare manufacturing facility in SG

It will be operational by mid-2026.

Sanofi inaugurated its $800m healthcare manufacturing facility, Modulus, located in Tuas Biomedical Park to be operational in mid-2026.

Modulus leverages an ‘industry-first’ modular concept that enables flexible manufacturing capabilities to produce next-generation vaccines and biological medicines.

It can be adapted to manufacture up to four vaccines or biopharmaceuticals simultaneously and be reconfigured to change over between pre-established technological platforms.

The facility can also house 34 standardised production modules, each equipped with interconnected and modular equipment to configure production lines rapidly according to specific needs.

Moreover, the site will generate 200 new jobs in Singapore including bioprocess engineers, automation specialists, data analysts, quality control experts, and specialists in artificial intelligence, machine learning, and bioinformatics.

Furthermore, it will make use of green technology such as solar panels, green electricity, and recycled materials in its construction.

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.